ANATOMÍA PATOLÓGICA E HISTORIA DE LA CIENCIA
Departamento
Pedro
Sánchez Rovira
Publicaciones en las que colabora con Pedro Sánchez Rovira (23)
2022
2019
-
Hydroxytyrosol supplementation modifies plasma levels of tissue inhibitor of metallopeptidase 1 in women with breast cancer
Antioxidants, Vol. 8, Núm. 9
-
Modulation by hydroxytyrosol of oxidative stress and antitumor activities of paclitaxel in breast cancer
European Journal of Nutrition, Vol. 58, Núm. 3, pp. 1203-1211
2018
-
Activating transcription factor 4 modulates TGFb-induced aggressiveness in triple-negative breast cancer via SMad2/3/4 and mTORC2 signaling
Clinical Cancer Research, Vol. 24, Núm. 22, pp. 5697-5709
2017
-
A plasma metabolomic signature discloses human breast cancer
Oncotarget, Vol. 8, Núm. 12, pp. 19522-19533
2014
-
EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
Oncotarget, Vol. 5, Núm. 17, pp. 7486-7497
-
Hydroxytyrosol ameliorates oxidative stress and mitochondrial dysfunction in doxorubicin-induced cardiotoxicity in rats with breast cancer
Biochemical Pharmacology, Vol. 90, Núm. 1, pp. 25-33
-
Tumor histological subtyping determined by hormone receptors and HER2 status defines different pathological complete response and outcome to dose-dense neoadjuvant chemotherapy in breast cancer patients
Clinical and Translational Oncology, Vol. 16, Núm. 6, pp. 548-554
2013
-
CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy
International Journal of Cancer, Vol. 133, Núm. 10, pp. 2398-2407
-
Impact of Diet on Breast Cancer Risk: A Review of Experimental and Observational Studies
Critical Reviews in Food Science and Nutrition, Vol. 53, Núm. 1, pp. 49-75
-
The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: An old tool with an enduring prognostic value
Clinical Breast Cancer, Vol. 13, Núm. 2, pp. 146-152
-
Transcriptional Shift Identifies a Set of Genes Driving Breast Cancer Chemoresistance
PLoS ONE, Vol. 8, Núm. 1
2012
-
Biomarkers characterization of circulating tumour cells in breast cancer patients
Breast Cancer Research, Vol. 14, Núm. 3
-
Oxidative stress status in metastatic breast cancer patients receiving palliative chemotherapy and its impact on survival rates
Free Radical Research, Vol. 46, Núm. 1, pp. 2-10
2011
-
Circulating cancer cells in division in an early breast cancer patient
Annals of Oncology
-
Does chemotherapy-induced oxidative stress improve the survival rates of breast cancer patients?
Antioxidants and Redox Signaling, Vol. 15, Núm. 4, pp. 903-909
-
Free radicals in breast carcinogenesis, breast cancer progression and cancer stem cells. Biological bases to develop oxidative-based therapies
Critical Reviews in Oncology/Hematology, Vol. 80, Núm. 3, pp. 347-368
-
Hydroxytyrosol inhibits growth and cell proliferation and promotes high expression of sfrp4 in rat mammary tumours
Molecular Nutrition and Food Research, Vol. 55, Núm. SUPPL. 1
2010
-
Gene-expression profiles, tumor microenvironment, and cancer stem cells in breast cancer: Latest advances towards an integrated approach
Cancer Treatment Reviews, Vol. 36, Núm. 6, pp. 477-484
-
Hydroxytyrosol: From laboratory investigations to future clinical trials
Nutrition Reviews, Vol. 68, Núm. 4, pp. 191-206